Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Bioscience
Clean Technology
Information Technology
Medical Device

LambdaVision

About: LambdaVision is designing and developing an innovative, protein-based retinal implant that utilizes the light-activated protein, bacteriorhodopsin, to stimulate the retina of patients suffering from impaired vision or loss of sight due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP).

Web: http://www.lambdavision.com/

CI Representative:
Daniel Wagner
Managing Director, Investments

[photo]